Skip to main content
OTLC filings

Corporate insider profile

Vuong Trieu Filing Activity

Latest reported as CHAIRMAN AND CEO of Oncotelic Therapeutics, Inc. (OTLC).

Purchase filings
2
Reported companies
1
Net open-market value
$26,483
Latest transaction
Jun 22, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Jun 22, 2026Oncotelic Therapeutics, Inc. (OTLC)CHAIRMAN AND CEOOpen Market Purchase255,000$0.05$11,475
Jun 15, 2026Oncotelic Therapeutics, Inc. (OTLC)CHAIRMAN AND CEOOpen Market Purchase335,759$0.04$15,008